SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Derivatives -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (529)11/6/2001 8:31:58 AM
From: rkrw  Respond to of 555
 
If it makes you feel any better, prior to marisa results as I recall, cvtx was very weak and in fact was trading in the single digits.

I agree with miljenko, I expect favorable results but what matters is how favorable.

cv imo is a robust company with a strong pipeline ex-ranolazine, so worst case, cv will be a cheap stock, strong mgt, strong pipeline and a lot of cash. I don't expect it, but if the trials happens to have bombed, I'll be buying.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News